Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRE
PRE logo

PRE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Prenetics Global Ltd (PRE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
20.500
1 Day change
3.25%
52 Week Range
23.630
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Prenetics Global Ltd (PRE) does not present a strong buy opportunity at the moment for a beginner investor with a long-term strategy. While the company has a positive analyst rating and a viable growth strategy, the technical indicators and options data suggest a lack of immediate upward momentum. Additionally, there are no significant catalysts or signals from Intellectia Proprietary Trading Signals to support a buy decision.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 53.073, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 20.246, with resistance at 21.812 and support at 18.68. However, the overall trend lacks strong upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The low open interest put-call ratio suggests bullish sentiment, but the high option volume put-call ratio indicates bearish short-term trading sentiment. Implied volatility is high at 101.97, but its percentile rank is low at 7.43, suggesting limited potential for significant price moves.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
9

Positive Catalysts

  • Analyst Benchmark initiated coverage with a Buy rating and a $30 price target, citing a viable long-term growth strategy and the company's focus on the growing nutritional supplements market.

Neutral/Negative Catalysts

  • No significant trading trends from hedge funds or insiders. Congress trading data is unavailable. Technical indicators and options data do not signal strong immediate upward momentum.

Financial Performance

Financial data for the latest quarter is unavailable, making it difficult to assess recent growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Benchmark initiated coverage with a Buy rating and a $30 price target, highlighting the company's long-term growth strategy and potential in the nutritional supplements market.

Wall Street analysts forecast PRE stock price to rise
Analyst Rating
0
Wall Street analysts forecast PRE stock price to rise
Buy
Hold
Sell
0
Current: 19.855
sliders
Low
0
Averages
0
High
0
0
Current: 19.855
sliders
Low
0
Averages
0
High
0
Benchmark
Buy
initiated
$30
AI Analysis
2026-06-16
New
Reason
Benchmark
Price Target
$30
AI Analysis
2026-06-16
New
initiated
Buy
Reason
Benchmark initiated coverage of Prenetics with a Buy rating and $30 price target. The health and wellness company is focused on IM8, its consumer brand addressing the growing nutritional supplements market that was co-founded by David Beckham, the analyst noted. The firm believes the company has a viable long-term growth strategy built on logical product expansion and adjacencies, further marketing channel diversification, and increasing global reach, the analyst tells investors.
Lake Street
initiated
$29
2026-03-16
Reason
Lake Street
Price Target
$29
2026-03-16
initiated
Reason
Lake Street initiated coverage of Prenetics with a Buy rating and $29 price target. Having divested three non-core assets, ACT Genomics, Europa, and its remaining stake in Insighta, Prenetics has generated more than $150M in proceeds while removing businesses that contributed little profitability and added operational complexity while shifting from a multi-division diagnostics and healthcare services company to a focused consumer health platform centered on its IM8 nutrition brand, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PRE
Unlock Now

People Also Watch